SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : World Outlook -- Ignore unavailable to you. Want to Upgrade?


To: Jeff Hayden who wrote (10473)4/4/2009 10:26:58 AM
From: Les H  Read Replies (1) | Respond to of 48868
 
if the barriers to entry in the drug industry were that low, then the pay-to-delay strategy wouldn't be so successful in maintaining high drug prices. DJ is presenting the side of big pharma in the article.



To: Jeff Hayden who wrote (10473)4/4/2009 3:12:12 PM
From: Skywatcher  Respond to of 48868
 
Drug companies are only interested in developing drugs that treat SYMPTOMS...cures put them out of business...